-
October 17, 2012
Johnson & Johnson has kicked off the US reporting season by posting a 7.3% decrease in earnings for the third quarter, hit by charges, but revealing healthy sales growth for its pharmaceuticals
Full story
-
July 23, 2012
Pharma sales in the six Gulf Cooperation Council (GCC) member states - Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the UAE - are set to grow by an average of 7% a year to 2020, say new estimates.
Full story
-
July 04, 2012
Observers have been reflecting on the recent decision by European leaders to adopt a unified patent system, something that has taken over 30 years
Full story
-
April 23, 2012
Merck KGaA's chief executive has been laying out his vision for the company's future, emphasising the need to cut costs and ruling out major deals
Full story
-
April 16, 2012
South Africa's government is finalising a list of more than 70 medicines which must in future be procured from domestic manufacturers.
Full story
-
March 22, 2012
The 2012 Budget unveiled by George Osborne yesterday includes measures aimed at making the UK "one of the most attractive places in the world to invent new medicines," the Chancellor told MPs.
Full story
-
March 21, 2012
Abbott Laboratories, which announced last October that it would spin off its $18 billion drugs arm, is calling the new unit AbbVie
Full story
-
March 16, 2012
This year marks "the steepest point of the so-called patent cliff" as many blockbuster drugs go off-patent, so global pharmaceutical firms are looking to Asia to counter falling revenue streams
Full story
-
December 06, 2011
Abbott Laboratories' chief executive Miles White has been talking about the rationale behind the recent decision to split the firm's business and dismissed rumours that its pharmaceuticals business will be sold off
Full story
-
December 01, 2011
After a nervous few hours, Ranbaxy Laboratories has received final approval in the USA to sell its generic version of Pfizer's cholesterol blockbuster Lipitor
Full story